Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
  • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
  • C12Q1/06—Quantitative determination
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
  • C12Q1/6844—Nucleic acid amplification reactions
  • C12Q1/6851—Quantitative amplification
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
  • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
  • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
  • C12Q1/18—Testing for antimicrobial activity of a material
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q2521/00—Reaction characterised by the enzymatic activity
  • C12Q2521/10—Nucleotidyl transfering
  • C12Q2521/101—DNA polymerase
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q2521/00—Reaction characterised by the enzymatic activity
  • C12Q2521/10—Nucleotidyl transfering
  • C12Q2521/119—RNA polymerase
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
  • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
  • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/90—Enzymes; Proenzymes
  • G01N2333/91—Transferases (2.)
  • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • G01N2333/91205—Phosphotransferases in general
  • G01N2333/91245—Nucleotidyltransferases (2.7.7)
  • G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
  • G01N2333/9126—DNA-directed DNA polymerase (2.7.7.7)
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/90—Enzymes; Proenzymes
  • G01N2333/91—Transferases (2.)
  • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • G01N2333/91205—Phosphotransferases in general
  • G01N2333/91245—Nucleotidyltransferases (2.7.7)
  • G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
  • G01N2333/9128—RNA-directed DNA polymerases, e.g. RT (2.7.7.49)
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2500/00—Screening for compounds of potential therapeutic value
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/02—Food

Definitions

• DNA polymerase activity is indispensable for genome replication and organism propagation across all biological domains (1-3). Procaryots contain five different types of DNA polymerases but mammalian cells contain fifteen distinct cellular DNA polymerases but only four of these are devoted to DNA replication, whereas the rest are devoted to DNA repair and specialized DNA synthetic processes that contribute substantially to the maintenance of genetic integrity. Although most of these enzymes are involved in nuclear DNA repair and replication, DNA polymerase gamma (Polg) remains the only DNA polymerase found in mitochondria (Hum. Mol. Genet. (1 July 2005) 14(13): 1775-1783).
• DNA polymerase activity Since its initial characterization (4), the ability to harness DNA polymerase activity in vitro has become a fundamental tool in the field of molecular biology research (5). Above and beyond its established importance in research, in vitro measurement of DNA polymerase activity potentially offers numerous useful applications within the pharmaceutical and clinical setting. For instance, since bacterial DNA polymerase is actively being targeted for development of novel antimicrobial agents (6, 7), a rapid and sensitive assay capable of measuring DNA polymerase activity is desirable. Also, loss or gain of DNA polymerase activity is intimately involved in human disease. For example, emerging links between DNA polymerase activity and genetic aberrations are designating the enzyme as a target for anti-cancer therapies (8, 9). Deficiencies in DNA polymerase activity have also been linked to mitochondrial disorders (10). Furthermore, measurement of DNA polymerase activity has the potential to be used as a rapid and sensitive diagnostic tool, capable of detecting virtually any organism harboring active DNA polymerase within a given environmental or biological matrix where sterility is expected.
• the various limitations of the above-described methodologies have been sought to be addressed, and a rapid, highly sensitive and quantitative assay is provided capable of measuring polymerase extension activity from purified polymerases or directly from crude cell lysates, or subcellular organelles.
• DNA polymerase extension activity is an indicator of cell viability, as demonstrated by the reproducibly strong concordance between assay signal viable cell enumerations.
• intact mammalian cells can also be quantitated and viability assessed by DNA polymerase extension assay.
• ETGA DNA polymerase extension coupled polymerase chain reaction
• DPE-PCR DNA polymerase extension coupled polymerase chain reaction
• FIG. 1 shows a basic overview of the novel DPE-PCR assay provided by the present invention.
• DNA polymerase is incubated with a substrate consisting of pre-annealed Oligo-1 and Oligo-2. DNA polymerase extends only the 3' end of Oligo-1 during a 20 minute incubation at 37°C.
• Three micro-liters of the DNA polymerase extension reaction mixture is subsequently transferred into a hot start qPCR reaction containing uracil DNA glycosylase (UDG).
• UDG uracil DNA glycosylase
• FIG. 1 A shows a schematic overview of the mechanisms involved in coupling DNA polymerase extension activity to qPCR.
• Figure 2A shows detection of DNA polymerase I extension activity in accordance with the present invention, achieved over a wide range of input enzyme.
• Figure 2 shows representations of sensitive detection of purified DNA polymerase using a preferred DPE-PCR assay in accordance with the present invention.
• a commercial source of DNA polymerase I was assayed in duplicate at 10 fold increments starting at 2 xlO 5 Units (U) down to 2x 10 "11 U per reaction.
• a representative DPE-PCR curve is shown for each polymerase input level and No Input Control (NIC).
• NIC No Input Control
• a representative DPE-PCR curve is presented for each of the assayed enzymes and NIC.
• Triplicate DPE-PCR curves are shown from corresponding DNA polymerase extension reactions containing a 50 ⁇ [dATP, dGTP, dTTP] mixture supplemented with 50 ⁇ of either dCTP or ddCTP.
• a schematic representing some of the first available sites for dCTP or ddCTP incorporation within the DNA substrate is presented adjacent to the DPE-PCR curves.
• Figure 2C shows that both Klenow and Klenow exo - were detected in accordance with the invention at similar levels when compared to wild type DNA polymerase I, providing evidence that the DPE-PCR assay signal is derived from DNA polymerase-dependent extension and not intrinsic exonuclease activity.
• Figure 2D illustrates the first possible position within the substrate that ddCTP can be incorporated by DNA polymerase.
• FIG 3 shows a schematic overview of coupling bead lysis to DPE-PCR, and illustrates a liquid sample known to contain, or suspected of containing, microbes, added to a bead mill lysis tube, disrupted and immediately transitioned into the DPE-PCR assay of the present invention.
• Figure 4 illustrates that a DPE-PCR assay in accordance with the present invention enables sensitive and quantitative detection of gram negative and gram positive bacteria via measurement of DNA polymerase extension activity in crude lysates. Decreasing amounts of E. coli cfu were spiked into bead lysis-coupled DPE-PCR. No Input Controls (NIC) were also included to monitor reagent background levels. All cfu spikes and NICs were performed in triplicate.
• Figure 5 illustrates that detection of bacteria by DPE-PCR is blocked by ddCTP.
• 5 of E. coli suspension were added to bead lysis-coupled DNA polymerase assays comprised of a dNTP mix containing either 50 ⁇ dCTP or 50 ⁇ ddCTP.
• DPE-PCR curves representing E. co //-derived DNA polymerase activity is presented. Plots were generated using the average qPCR Ct values from triplicate reactions at the indicated conditions.
• ddCTP termination and dCTP rescue experiments were performed for S. aureus exactly as described above for E. coli.
• Figures 5A and 5B when compared to the standard reaction mix, show that substitution of ddCTP blocked the generation of signal derived from E. coli, S. aureus cfu spikes.
• Figure 6 shows PC ETGA PCR Data generated by performance of preferred embodiments of the assay of the present invention.
• DNA polymerase extension activity could represent a useful tool with far reaching applications such as, but not limited to, screening candidate -polymerase inhibitors in vitro, or depending of cell selective sample preparation, detection of the presence any viable cell type (harboring active DNA polymerases) within a diverse range of sample types. If intended for these purposes, routine use of traditional polymerase assays that incorporate radiolabeled nucleotides is unattractive. Consequently, numerous non-radioactive DNA polymerase extension assays have been developed in recent decades. Despite successfully averting the use of radioactivity, current fluorescence -based DNA polymerase assays also suffer from various deficiencies.
• Figure 1 A contains a schematic overview of the mechanisms involved in coupling DNA polymerase extension activity to qPCR.
• Oligo 2 is eliminated by uracil DNA glycosylase (UDG) prior to and during Taq activation, thus preventing undesired Taq-dependent extension of the substrate just prior to PCR cycling.
• UDG uracil DNA glycosylase
• a microbial detection method linking T4 DNA ligase activity to PCR amplification has been previously reported (18), which contains similarities to our DPE-PCR assay and is another example of an ETGA methodology.
• DPE-PCR assay signal is derived from DNA polymerase-dependent extension of the DNA substrate prior to qPCR. Since incorporation of dideoxy nucleotides is a well established method used for termination of DNA polymerase chain extension activities (19,20), we chose to substitute dCTP with dideoxyCTP (ddCTP) within our DNA polymerase extension reaction mix.
• ddCTP dideoxyCTP
• the schematic shown in Figure 2D reveals the first possible position within the substrate that ddCTP can be incorporated by DNA polymerase. If ddCTP is incorporated into this position, the extension product of Oligo 1 would be insufficient in length for subsequent detection by qPCR primer 1 (See Figure 1 schematic).
• S. aureus and E. coli cultures were grown to an OD 6 oo of 1.0 ⁇ 0.2 (approximately 1 x 10 9 cfulmL.)
• OD 6 oo 1.0 ⁇ 0.2
• 1 mL of culture was pelleted and washed three times in T.E.
• Bacterial suspensions were serially diluted in T.E., and 5 ⁇ , of each stock were added to bead mill lysis tubes containing 50 DNA polymerase extension reaction mixture (see above for composition).
• a titration curve of 1 x 10 5 to 1 x 10° c w/reaction was performed in triplicate for each organism, including triplicate reactions without bacterial suspension.
• Bead mill lysis tubes are generated by pipetting 60 ⁇ , (wet volume) of 0.1mm glass beads (Scientific Industries cat# SI-GO 1) using a 100 size Eppendorf tip and 50 ⁇ , (wet volume) of 0.5mm glass beads (Scientific Industries cat# SI-BG05) using a modified 1000 ⁇ , size Eppendorf tip (To enable more reproducible and accurate dispensing of the 0.5mm beads, the end of the 1000 ⁇ ⁇ size Eppendorf tip was cut to a 1mm inner diameter using a sterile razor blade).
• sample tubes were placed at 37° C for 20 minutes. After the 20 minute incubation, sample tubes were transferred to 95° C for 5 min. and removed to cool at room temperature. Sample tubes were then spun at 12k x g for 30 seconds and 3 ⁇ , of each reaction were placed into the qPCR portion of the DPE-PCR assay. Five micro-liters of each bacterial stock was plated to obtain more accurate cfu input levels. Gene-specific PCR was also performed on the same lysates used for DNA polymerase detection.
• DNA substrate design and preparation The sequences of the DNA substrate were adapted from DNA oligos previously used to measure bacterial-derived ATP via T4 DNA ligase (18).
• Oligo 1 (5'- gccgatatcggacaacggccgaactgggaaggcgaga ctgaccgaccgataagctagaacagagagacaacaac -3') and Oligo 2 (5'- uaggcgucggugacaaacggccagcguuguugu cucu[dideoxyCytidine] -3') were
• Oligo 2 synthesized by Integrated DNA Technologies (Coralville, Iowa).
• the "u" in Oligo 2 represents deoxyUridine.
• DideoxyCytidine (ddC) was included as the last base on the 3' end of Oligo 2 to block DNA polymerase-mediated extension (see Figure 1 schematic).
• lyophilized Oligo 1 and Oligo 2 were resuspended to a final concentration of 100 ⁇ in sterile Tris-EDTA (T.E.) pH 8.0 (Ambion). Routine pre-annealing of the substrate was performed as follows.
• One hundred micro-liter aliquots of the 10 ⁇ oligo mixture was dispensed into thin-walled 0.2 mL PCR tubes, capped, placed into a GeneAmp® 9700 thermocycler (Applied Biosystems) and the following pre- annealing program was performed: 95° C for 2 minutes, ramp at default speed to 25° C and incubate for 5 minutes, ramp at default speed to 4° C.
• a substrate dilution buffer was prepared by diluting oligo annealing buffer (described above) 1 : 10 in sterile water (Ambion,
• the internal control sequence was synthesized and cloned as a "minigene” by Integrated DNA Technologies (Coralville, Iowa). Upon receipt, the internal control minigene plasmid was linearized using the restriction enzyme Pvul (New England Biolabs) and re -purified using a PCR cleanup column (Qiagen). The purified internal control was quantified using a Nanodrop spectrophotometer (Thermo Scientific, ND-1000), diluted to the desired concentration in T.E. and stored a -20° C. A probe, specific for the internal control DNA, was synthesized by
• DNA Pol I (NEB cat# M0209L), Klenow (NEB cat# M0210S) and Klenow exo(-) (NEB cat# M0212S) were diluted to the indicated ⁇ / ⁇ stock in sterile T.E. pH 8.0.
• NIC No Input Control
• DNA polymerase extension reactions were prepared as described above with a 50 ⁇ [dATP, dGTP, dTTP] mixture supplemented with either 50 ⁇ dCTP or 50 ⁇ ddCTP (Affymetrix #77332.) 50 ⁇ , DNA polymerase extension reactions with a 50 ⁇ [dATP, dGTP, dTTP] mixture, supplemented with either dCTP or ddCTP, were spiked with 2 ⁇ , of a 1 x 10 "9 U/ ⁇ stock of DNA polymerase I (New England Biolabs # M0209). Triplicate reactions were incubated at 37° C for 20 minutes and 3 ⁇ , of each reaction were subsequently placed into qPCR.
• DNA polymerase extension reaction reagent stocks (minus DNA substrate) were heat treated as follows: 10X dNTP mixture [500 ⁇ dATP, dCTP, dGTP, dTTP] was heated at 90 0 C for 30 minutes. 10X core reaction mix [200 mM Tris pH 8.0, 100 mM Ammonium sulfate, 100 mM Potassium chloride, 20 mM Magnesium sulfate] was heated at 90 0 C for 30 minutes. 1.43X BSA/Detergent mix [1.43 % BSA, 0.143 % Triton X-100, 0.143 % Tween 20] was heated at 75 0 C for 45 minutes.
• Substrate annealing buffer 200 mM Tris, 100 mM Potassium chloride and 0.1 mM EDTA pH 8.45 was heated at 90 0 C for 30 minutes. Bead mill tubes were heated at 95 0 C for 20 minutes.
• a simple, sensitive and universal method that measures microbial-derived DNA polymerase activity would be highly desirable.
• measurement of DNA polymerase extension activity could be used to screen environmental or biological samples for the presence of any microorganism harboring active DNA polymerase.
• a simple method that couples microbial lysis to our DPE-PCR assay As shown in Figure 3, a liquid sample known to contain, or suspected of containing, microbes is added to a bead mill lysis tube, disrupted and immediately transitioned into the DPE-PCR assay.
• the DPE-PCR assay when linked with bead mill lysis, is capable of detecting a wide dynamic range of input E. coli, down to and below 10 colony forming units ⁇ cfu) per lysis tube. Linear regression analysis of E. coli detection was also performed down to 10 cfu of input bacteria and showed a strong positive linear correlation between input cfu and DNA polymerase extension activity signal as indicated by an R value of 0.999 ( Figure 4B). Colony count plating and E.
• Table 1 The following table shows data representative of sensitive and linear detection of 17 additional clinically relevant microbial species, using preferred embodiments of the assay of the present invention. Table 1
• the DPE-PCR assay can be used to assess bacterial cell viability was provided via the reproducibly strong correlation between DNA polymerase extension activity and proliferation as indicated by the presence of cfu.
• the ETGA methodology exemplified by the DPE-PCR assay of the present invention has the potential to become a useful quantitative tool for a wide range of testing applications within pharmaceutical, environmental, food and clinical settings.
• PC Bacterial Culture Plated with 100 uL of PC to verify sterility (In most cases, 8 mL of PC were also inoculated into both aerobic and anaerobic blood culture bottles to verify sterility of the PC unit). Plates incubated at 37 for 48hrs, colony number recorded. Blood culture bottles inoculated were incubated in automated incubator for 5 days. Spin at 8000 x g for 3 min Pour off supernatant and invert tube onto a plastic-backed lab wipe (Thomas Cat#
• Cell Lysis Add 50 ul lysis mix to each beadmill tube Place beadmill tubes into disrupter head and vortex at 2800 rpm for 6 min Add 5 ul of DNA polymerase (the pre-diluted PC stock) to the DNA pol control tube and briefly vortex
• Enzymatic modification of Substrate Place each tube at 37° C for 20 min. Transfer each tube to 95° C heat block for 5 min. Assemble PCR master mix (x2) during the 5 min. incubation.
• DNA polymerase was proven to account for all the measured extension activity via ddCTP chain termination experiments.
• ETGA assay detects high levels of DNA polymerase signal from sterile intact platelet concentrates following bead mill membrane disruption regardless of the method of PC preparation.
• This mammalian PC ETGA signal is expected to be predominantly from platelet derived mitochondrial gamma-DNA polymerase activity as platelets are devoid of nuclei.
• minor polymerase signal contribution cannot be ruled out from contaminating nucleated white blood cells.
• all mammalian blood cell types, except for red blood cells which lack both nucleus and mitochondria will produce strong DNA polymerase signals.
• any mammalian cell containing a nucleus or mitochondria is a candidate for detection and quantification via this novel assay of the present invention.
• Organism Lysis Add 50 ul lysis mix to each beadmill tube Place beadmill tubes into disrupter head and vortex at 2800 rpm for 6 min
• ETGA assay methods performed in accordance with the present invention are capable of detection of DNA polymerase extension activity associated with in vitro cultured Hep2 cells. It is reasonably assumed that this assay method can detect any DNA polymerase from any intact viable cell and or their polymerase harboring subcellular organelles such as nuclei, mitochondria etc.
• HIV Human Immunodeficiency Virus
• Recombinant HIV RT (Calbiochem cat#382129) Assemble the following reaction mix using reagents supplied with the SSIII kit (Invitrogen):
• RNA-oligonucleotide Detection of HIV reverse transcriptase activity using only a simple AS-oligo substitution RNA-oligonucleotide has been demonstrated as enabled by the novel assay of the present invention.
• Reagent background T.E. only
• UNG UNG within the PCR
• This example demonstrates that HIV reverse transcriptase can be substituted in place of DNA polymerase for detection and quantification of RT enzyme activity and or any cell or subcellular organelle component that harbors active HIV RT or a viable viroid.

Landscapes

• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Molecular Biology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Immunology (AREA)
• Microbiology (AREA)
• Biophysics (AREA)
• Analytical Chemistry (AREA)
• Physics & Mathematics (AREA)
• Genetics & Genomics (AREA)
• Biochemistry (AREA)
• Biotechnology (AREA)
• General Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Toxicology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
• Enzymes And Modification Thereof (AREA)
• Investigating Or Analysing Biological Materials (AREA)

Priority Applications (8)

Applications Claiming Priority (2)

Publications (1)

Family

ID=49328180

Family Applications (1)

Country Status (9)

Cited By (2)

Families Citing this family (1)

Citations (3)

Family Cites Families (4)

• 2013
  • 2013-04-12 WO PCT/US2013/036264 patent/WO2013155361A1/en active Application Filing
  • 2013-04-12 CA CA2908941A patent/CA2908941A1/en not_active Abandoned
  • 2013-04-12 EP EP13775260.6A patent/EP2836610A4/en not_active Withdrawn
  • 2013-04-12 US US14/391,758 patent/US20160083776A1/en not_active Abandoned
  • 2013-04-12 JP JP2015505927A patent/JP2015513921A/ja active Pending
  • 2013-04-12 CN CN201380019842.5A patent/CN104520438A/zh active Pending
  • 2013-04-12 AU AU2013245832A patent/AU2013245832A1/en not_active Abandoned
  • 2013-04-12 IN IN9421DEN2014 patent/IN2014DN09421A/en unknown
  • 2013-04-12 KR KR1020147031688A patent/KR20150009539A/ko not_active Application Discontinuation

Patent Citations (3)

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events